Furthermore, mRNA and protein expression of BRD4-dependent genes, including c-Myc, Bcl-2, and cyclin D1, was significantly decreased in A1874-treated colon cancer cells (Fig. 3a, b). This evidence concerns the gene BCL2 and malignant colon neoplasm.